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ndogenous oxidants participate in endothelial cell
migration, suggesting that the enzymatic source of
oxidants, like other proteins controlling cell mi-
gration, requires precise subcellular localization for spa-
tial conﬁnement of signaling effects. We found that the
nicotinamide adenine dinucleotide phosphate reduced
(NADPH) oxidase adaptor p47
 
phox
 
 and its binding part-
ner TRAF4 were sequestered within nascent, focal com-
plexlike structures in the lamellae of motile endothelial
cells. TRAF4 directly associated with the focal contact
scaffold Hic-5, and the knockdown of either protein, dis-
ruption of the complex, or oxidant scavenging blocked
E
 
cell migration. An active mutant of TRAF4 activated the
NADPH oxidase downstream of the Rho GTPases and
p21-activated kinase 1 (PAK1) and oxidatively modiﬁed
the focal contact phosphatase PTP-PEST. The oxidase also
functioned upstream of Rac1 activation, suggesting its
participation in a positive feedback loop. Active TRAF4
initiated robust membrane rufﬂing through Rac1, PAK1,
and the oxidase, whereas the knockdown of PTP-PEST in-
creased rufﬂing independent of oxidase activation. Our
data suggest that TRAF4 speciﬁes a molecular address
within focal complexes that is targeted for oxidative mod-
iﬁcation during cell migration.
 
Introduction
 
Migrating cells engage in the cyclic formation and dissolution
of points of contact between the lamellipodium and the matrix,
creating transitory integrin clusters termed focal complexes
(Nobes and Hall, 1995). Although generally smaller than ma-
ture focal adhesions, leading edge focal complexes bear the
strongest tensile forces in migrating cells (Beningo et al.,
2001). In theory, the turnover of focal complexes at the leading
edge may be necessary for the constantly remodeling lamelli-
podium to simultaneously translocate forward while also retain-
ing the ability to retract and change direction based on matrix
sampling or soluble chemoattractant gradients. Accordingly,
interventions that either interrupt or stabilize focal complex
formation impair normal cell migration (Rottner et al., 1999;
Totsukawa et al., 2004; Webb et al., 2004). These same inter-
ventions may also diminish membrane ruffling, suggesting
that the latter may occur from tension applied to segments of
lamellipodia that are transiently unanchored as a result of re-
gionally high focal complex turnover.
Focal complex dynamics, in turn, appear to be coordi-
nated by the Rho family of small GTPases. Whereas Rac1 and
Cdc42 promote focal complex formation within lamellipodia
and filopodia, RhoA facilitates the maturation of focal com-
plexes into stable focal adhesions (Nobes and Hall, 1995;
Rottner et al., 1999). To fully polarize these events in the motile
cell so that meaningful locomotion can occur, positive feed-
back loops are initiated, resulting in the rapid amplification of
Rho GTPase and p21-activated kinase 1 (PAK1) activation at
the leading edge and, thus, asymmetric formation of a lamelli-
podium (Li et al., 2003). The mechanism by which the small
GTPases control focal contact behavior is incompletely under-
stood, but it involves the initiation of protein tyrosine phophor-
ylation events leading to intense tyrosine phosphorylation of
focal contact proteins. Rac1 and RhoA, for instance, direct the
tyrosine kinase Src to lamellipodia and focal adhesions, re-
spectively, to cause remodeling of these integrin-containing
structures (Timpson et al., 2001; Webb et al., 2004). Src, in
turn, facilitates full activation of the related focal adhesion
tyrosine kinase (Pyk2), and both tyrosine kinases are required
for the phosphorylation of a number of focal complex proteins.
Opposing these effects, the protein tyrosine phosphatase
PTP-PEST is also directed to nascent integrin clusters, where it
dephosphorylates and thus inactivates Pyk2 (Lyons et al.,
2001; Sastry et al., 2002). Furthermore, PTP-PEST suppresses
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Rac1 activation at the leading edge, diminishing the polariza-
tion of migrating cells (Sastry et al., 2002). Although PTP-
PEST is thought to target focal contacts through direct binding
to paxillin and the paxillin paralogue Hic-5, the mechanism by
which its activity is regulated is unclear.
Besides controlling focal complexes and lamellipodia at
the leading edge of cells, Rac1 is necessary for activation of the
NADPH oxidase. Recently, this oxidase was shown to mediate
endothelial cell migration in a Rac1-dependent manner (Mol-
dovan et al., 2000; Ushio-Fukai et al., 2002). Oxidant activity
was noted to localize to membrane ruffles (Moldovan et al.,
2000), suggesting that distinct functions of Rac1—oxidase
activation and control of lamellipodial dynamics—may be
spatially and functionally coordinated at the leading edge of
migrating cells. Such physical targeting of a tightly regulated
oxidant source would present a logical explanation for the ob-
served specificity of oxidant signaling in response to migratory
stimuli, circumventing the rapid diffusion and limited target
specificity of oxidant molecules themselves. Therefore, we
sought to identify molecular targeting devices that may specify
the site of oxidant production and, thereby, focus their effects.
We previously reported that the orphan adaptor TRAF4
directly binds the NADPH oxidase subunit p47
 
phox
 
 and controls
activation of the c-Jun NH
 
2
 
-terminal kinase (JNK) MAPK
(Xu et al., 2002). Notably, mice lacking TRAF4 display defec-
tive branchial somite and neural tube closure, and flies lacking
the orthologous dTRAF1 fail to activate JNK and complete
dorsal closure; both phenotypes suggest abnormal migration
(Regnier et al., 2002; Cha et al., 2003). In this study, we found
that both TRAF4 and p47
 
phox
 
 target focal complexes in association
with Hic-5 and initiate Rho GTPase signaling. TRAF4-directed
oxidant production selectively targets the redox-sensitive phos-
phatase PTP-PEST and may participate in a positive feedback
cycle that facilitates Rac1 activation.
 
Results
 
TRAF4 and p47
 
phox
 
 concentrate in focal 
complexes
 
In spontaneously migrating endothelial cells, the distribution of
TRAF4-GFP was polarized, concentrating in small discontinuous
patches near the lamellipodial edge (Fig. 1 A). Because this
pattern resembles that of focal complexes, we examined the
colocalization of TRAF4 with zyxin, a scaffolding protein that
appears in focal complexes and also accumulates in focal adhe-
sions (Krylyshkina et al., 2003; Franco et al., 2004; Totsukawa
et al., 2004). By confocal microscopy, TRAF4-GFP was found
to localize within discrete, peripheral DsRed-zyxin aggregates
of variable size at the leading edge of endothelial cell lamellar
protrusions (Fig. 1 B), along occasional microspike shafts and
tips, and discontinuously in a peripheral rim around newly ad-
herent cells, which is consistent with focal complex association
(Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200507004/DC1). In contrast, TRAF4-GFP accumulation
in stable stress fiber–associated focal adhesions was weak or
absent (Fig. 1 B). The ventral location of TRAF4-GFP was
assessed using total internal reflection fluorescence (TIRF)
microscopy, which narrows the z-axis resolution to within
100–150 nm of the coverslip surface. Relatively nonpolarized
cells showed accurate colocalization of TRAF4-GFP with
Figure 1. TRAF4 accumulates in focal complexes. HUVECs were transfected with the indicated plasmids (color of font indicates pseudocolor designation),
plated on fibronectin-coated coverslips, and examined live without fixation using confocal (A and B) or TIRF (C) microscopy. (A) TRAF4-GFP translocated
to the tips of leading edges (right), a pattern not seen with pEGFP (left). (B) HUVECs were cotransfected with TRAF4-GFP and DsRed-zyxin. Insets show
appearance of TRAF4-GFP and DsRed-zyxin in discontinuous structures at the leading (right) edge of a large protrusion (arrows). Larger stress fiber–anchored
focal adhesions contain DsRed-zyxin but no detectable TRAF4-GFP (top insets). (C) TIRF microscopy image of TRAF4-GFP and DsRed-zyxin showing ventral
location of small TRAF4-GFP and DsRed-zyxin focal complexes at an advancing protrusion (top inset). Larger DsRed-zyxin focal adhesions lacked
TRAF4-GFP (bottom inset). (D) Immunofluorescent images of fixed cells were obtained using TIRF microscopy showing colocalization of endogenous TRAF4
(labeled with AlexaFluor488) within small (closed head arrows) to medium (open head arrow)-sized vinculin aggregates (AlexaFluor555) appearing at the
edge of a protrusion. Bars (A–C), 20  m; (D) 10  m. 
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peripheral DsRed-zyxin aggregates, confirming targeting to
juxtamembrane structures (Fig. S2). In more polarized mo-
tile cells, TRAF4-GFP preferentially associated with nascent
DsRed-zyxin clusters of variable size at the active leading edge
of lamellae, but much less so with larger, rearward focal adhe-
sions (Fig. 1 C). In parallel, immunofluorescent images demon-
strated colocalization of endogenous TRAF4 to small (
 
 
 
1 
 
 
 
m)
vinculin-containing structures at the edge of human umbilical
vein endothelial cell (HUVEC) protrusions, which is again con-
sistent with its early appearance in focal complexes (Fig. 1 D).
The distribution of DsRed-p47 also became highly po-
larized in migrating endothelial cells, concentrating in zyxin-
containing structures within lamellar protrusions (Fig. 2 A).
In addition, faint linear accumulation of DsRed-p47 was fre-
quently seen at the outer edge of protrusions before visible or-
ganization of zyxin-GFP aggregates. DsRed-p47 was not found
within stable focal adhesions in either mobile or static cells.
TIRF microscopy also revealed the early appearance of DsRed-
p47 at both linear and dotlike ventral structures at the periphery
of advancing edges, partially coinciding with zyxin-GFP accu-
mulation (Fig. 2 B). In addition, p47
 
phox
 
 specifically coprecipi-
tated with GFP-zyxin (not depicted), which is consistent with
its incorporation into focal complex assemblies. By immuno-
fluorescence, endogenous p47
 
phox
 
 accurately colocalized with
small- to medium-sized vinculin aggregates (Fig. 2 C), and
p47
 
phox
 
 colocalized with endogenous TRAF4 at the tips of pro-
trusions, which is again consistent with an association within
focal complexes (Fig. 2 D).
 
TRAF4 binds the focal contact protein 
Hic-5
 
Using full-length TRAF4 as a Gal4-binding domain bait fusion
in a yeast two-hybrid screen, two clones were retrieved from an
endothelial cell Gal4 activation domain library (Xu et al.,
2002) containing residues 45–444 of Hic-5, including the three
LD motifs and four COOH-terminal LIM domains. Yeast
mating studies demonstrated interactions between p47
 
phox
 
 and
TRAF4 and TRAF4 and Hic-5 but not between p47
 
phox
 
 and
Hic-5 (unpublished data). Binding of TRAF4 to Hic-5 was di-
rect, as indicated by specific pull down of in vitro translated
Hic-5 by GST-TRAF4 (Fig. 3 A). Ectopically expressed
TRAF4 and Hic-5 cross-coimmunoprecipitated in Phoenix-293
cells (Fig. 3 B), and endogenous TRAF4 coimmunoprecipitated
with endogenous Hic-5 in lung microvascular endothelial cells
(Fig. 3 C).
Hic-5, like its paralogue paxillin, is directed to focal ad-
hesions through interaction with focal contact proteins. Unlike
paxillin, Hic-5 has been demonstrated to have a stronger physi-
cal and functional association with the kinase scaffold Pyk2
(related focal adhesion tyrosine kinase CAK
 
 
 
), which is
known to target focal complexes (Litvak et al., 2000), than with
the related kinase FAK (Osada et al., 2001). Immunoprecipitation
of endogenous Pyk2 brought down detectable amounts of en-
dogenous TRAF4 and Hic-5 (Fig. 3 C), which is consistent
with an association of the three focal complex proteins. In
addition, Pyk2 coprecipitated ectopically expressed wild-type
p47
 
phox
 
 and, to a greater extent, the active (open conformation)
mutant p47(S303D,S304D,S328D) (Wu et al., 2003) but not
the inactive SH3 surface-disrupted mutant p47(W193R) (Fig.
3 D), suggesting that formation of the complex may be associated
with the activation state of the oxidase. By TIRF microscopy,
DsRed-TRAF4 was found within some but not all Hic-5–GFP
focal accumulations (Fig. 3 E). Immunofluorescent stains dem-
onstrated the association of endogenous Hic-5 with vinculin
aggregates of various sizes, confirming an association with
focal contact structures (Fig. 3 F). Finally, triple labeling studies
confirmed the colocalization of endogenous Hic-5 and TRAF4
within small- to medium-sized vinculin aggregates at the periph-
ery of lamellipodia (Fig. 3 G).
 
TRAF4–Hic-5 interactions control cell 
migration
 
Because focal complex formation is critical to cell migration,
we next asked whether TRAF4–Hic-5 interactions were impor-
tant for such migration. First, we found that short inhibitory
RNA (siRNA)–mediated knockdown of either endogenous
Figure 2. p47
phox associates with TRAF4 in focal
complexes. (A) Confocal image of DsRed-p47
in small, discrete zyxin-GFP–containing com-
plexes within the leading (right) lamellar
edge. Stress fiber–associated focal adhesions
(top inset) lack DsRed-p47. DsRed-p47 also
localized to the periphery (arrow). (B) TIRF
image shows ventral appearance of DsRed-
p47 with nascent zyxin-GFP aggregates at the
leading edge of a protrusion. (C) Immunofluo-
rescent image of endogenous p47
phox
(AlexaFluor488) showing colocalization with
small vinculin (AlexaFluor555) accumula-
tions. (D) Immunofluorescent image showing
the appearance of endogenous TRAF4
(AlexaFluor488) and p47
phox (AlexaFluor633)
in small dotlike structures at the edge of a
protrusion (arrows). B–D, TIRF images. Bars
(A and B), 20  m; (C and D) 10  m. 
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TRAF4 or Hic-5 diminished HUVEC migration across fibronec-
tin-coated filters in response to a VEGF gradient (Fig. 4 A).
Furthermore, the superoxide dismutase mimetic MnTMPyP
also inhibited endothelial cell migration, which is consistent
with a role for oxidants in migration. Next, to determine relevant
binding domains, truncations of each protein were expressed in
vivo to preserve zinc finger structures. COOH-terminal trunca-
tions of Hic-5, which resulted in serial loss of the four COOH-
terminal LIM domains and three LD motifs, revealed that only
full-length Hic-5 coprecipitated with TRAF4 (Fig. 4 B), indicat-
ing that the COOH-terminal LIM domain 4 (residues 388–444)
was necessary for TRAF4 binding. In addition, the Hic-5 LIM
Figure 3. TRAF4 associates with Hic-5. (A) In vitro–translated full-length Hic-5 was specifically pulled down by GST-TRAF4, not by GST or beads alone.
Top panel is an autoradiogram of captured 
35S-methionine–Hic-5; bottom panel is Coomassie stain of GST fusion input. (B) Phoenix-293 cells were trans-
fected with TRAF4 with or without Hic-5 and immunoprecipitated with antibodies against Hic-5 (left), TRAF4 (right), or irrelevant antibodies. Immunoblots
were sequentially probed for Hic-5 and TRAF4. Hic-5 appears as a doublet straddling the Ig heavy chain (HC). (C) Lysate from untransfected human lung
microvascular endothelial cells was immunoprecipitated with antibodies for TRAF4 or Pyk2 and immunoblotted as shown. Endogenous Hic-5 coprecipi-
tated with TRAF4 and both TRAF4 and Hic-5 coprecipitated with Pyk2. (D) HUVEC were infected with adenoviruses harboring lacZ, p47
phox(wt),
p47(W193R), or p47(S303D,S304D,S328D) (MOI   100:1). 24 h later, lysate was immunoprecipitated for Pyk2 and immunoblotted for p47
phox and
Pyk2. Bottom panel shows total p47
phox. (E) Partial colocalization of Hic5-GFP and DsRed-TRAF4 at focal structures within the membrane edge (arrows) is seen.
(F) Immunofluorescent image showing the presence of endogenous Hic-5 (AlexaFluor633) in small- to medium-sized vinculin (AlexaFluor555) structures at
the edge of a protrusion (arrows). (G) Immunofluorescent stain showing the simultaneous appearance of TRAF4 (AlexaFluor488), Hic-5 (AlexaFluor633),
and vinculin (AlexaFluor555) in small (closed head arrow) to medium (open head arrow)-sized complexes at the periphery of a lamella. E–G are TIRF
microscopy images. Bars (E and F), 10  m; (G) 20  m. 
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domain 4 in isolation did not coprecipitate with TRAF4,
whereas the tandem LIM domains 3 and 4 (L3,4) did (Fig. 4 C).
Thus, LIM domains 3 and 4 are each necessary but insufficient
for TRAF4 binding. Conversely, full-length Hic-5 coprecipi-
tated the COOH-terminal TRAF domain of TRAF4 (TRAF4-C)
but not the NH
 
2
 
-terminal remainder containing the ring and
zinc fingers (Fig. 4 D). Thus Hic-5(L3,4) binds the COOH ter-
minus of TRAF4.
Truncations comprising these two binding domains were
then used to disrupt interactions between native proteins. Ectopic
expression of either Hic-5(L3,4) or TRAF4-C, marked by
cotransfection with GFP, abrogated VEGF-induced migration
Figure 4. TRAF4–Hic-5 interactions affect endothelial
cell migration. (A) HUVEC were transfected with
siRNA against either TRAF4 or Hic-5, and migra-
tion across filters in response to a VEGF gradient
was measured. Immunoblots show protein levels
48 h after transfection. Control siRNA was
against luciferase. 100  M MnTMPyP was
present only during the 16-h migration period.
Knockdown of Hic-5 or TRAF4 or antioxidant
treatment decreased VEGF-induced migration of
HUVEC. hpf, high-powered field. (B) Phoenix-293
cells were cotransfected with full-length TRAF4
and Flag-tagged Hic-5 truncations as indicated.
Immunoblots of lysates before TRAF4 immunopre-
cipitation are shown as input. Cartoon below dia-
grams Hic-5 truncations showing NH2-terminal
Flag tag, three LD motifs (shaded), and four
COOH-terminal LIM domains (open). Only full-
length Flag–Hic-5 containing LIM 4 coprecipitated
with TRAF4 (first lane). (C) Phoenix-293 cells were
cotransfected with full-length TRAF4 and full-length
Flag–Hic-5 (FL), Flag–Hic-5(329–444) (LIM3,4),
or Flag–Hic-5(388–444) (LIM4). Lysates before
TRAF4 immunoprecipitation were immunoblotted
for Hic-5 and reprobed for TRAF4 to show input.
Top panel shows coprecipitation of full-length
Flag–Hic-5 and Flag–Hic-5(329–444) but not
Flag–Hic-5(388–444) with TRAF4. (D) Phoenix-
293 cells were cotransfected with full-length Flag–
Hic-5 and either Flag-TRAF4(1–260) (TRAF4-N) or
Flag-TRAF4(261–470) (TRAF4-C). Lysate was im-
munoblotted with anti-Flag (bottom) to show Hic-5
and TRAF4 inputs simultaneously. After immuno-
precipitation with anti–Hic-5, blots were probed
with anti-Flag to demonstrate the recovery of
Flag–TRAF4-C but not Flag–TRAF4-N. Ig heavy and
light chains (HC and LC) are shown. (E) HUVEC
were cotransfected with pEGFP and empty vector
(pCIN), TRAF4-C, or Hic-5(LIM3,4). GFP-expressing
cells migrating across 8- m pore filters in response
to a VEGF gradient is shown. Migration in re-
sponse to VEGF was blocked by the coexpression
of either TRAF4-C or Hic-5(LIM3,4). (A and E) *, P  
0.05 compared with no VEGF control; 
†, P  
0.05 compared with VEGF control. (F) Discrete
DsRed-p47 dotlike structures characteristically
appeared at the edges of lamellar protrusions
(arrows). Bar, 20  m. Cotransfection of HUVEC
with TRAF4-C or knockdown of endogenous
TRAF4 or Hic-5 decreased the number of cells (*,
P    0.05) with such DsRed-p47 structures. (G)
HUVEC were cotransfected as in D and plated on
fibronectin-coated etched coverslips. Phase-contrast
and epifluorescent (green) images were obtained
immediately after wounding and at 16 and 24 h
after wounding. (H) Histogram represents mean
speed of GFP-expressing cells migrating into the
wound. Entry of GFP-expressing cells into the
wound was decreased by the coexpression of
TRAF4-C or Hic-5(LIM3,4). Non–GFP-expressing
cells migrated into wounds at comparable
speeds. Error bars represent SEM. *, P   0.05
compared with vector alone. 
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(Fig. 4 E). Consistent with the ability of TRAF4 to direct
p47
 
phox
 
 to focal complexes, the expression of TRAF4-C, which
also contains the p47
 
phox
 
-binding site, or the knockdown of ei-
ther TRAF4 or Hic-5 caused the delocalization of DsRed-p47
from its sites of peripheral focal accumulation (Fig. 4 F). In
addition, GFP-cotransfected cells expressing Hic-5(L3,4) or
TRAF4-C failed to participate in sheet migration into mono-
layer wounds despite wound closure by nontransfected cells
(Fig. 4, G and H), providing further evidence for a functional
TRAF4–Hic-5 complex.
 
Myr-TRAF4 activates Rho GTPases, 
PAK1, and the NADPH oxidase
 
An active mutant of TRAF4 was created through NH
 
2
 
-terminal
fusion with the c-Src myristoylation motif (Myr-TRAF4). Myr-
TRAF4 was isolated from detergent-resistant low density
membrane fractions, which is consistent with raft localization,
and also from the insoluble pellet fraction, which is consistent
with  cytoskeletal association (Fig. S3, available at http://
www.jcb.org/cgi/content/full/jcb.200507004/DC1). Surpris-
ingly,  both endogenous TRAF4 and overexpressed native
TRAF4 also quantitatively partitioned with raft fractions, al-
though cytoskeletal association was weak. Raft localization of
TRAF4 is consistent with the site of integrin activation upon
matrix attachment (Lacalle et al., 2002; Labrecque et al., 2003).
The Rho family of small GTPases associate avidly with
raft domains upon activation (del Pozo et al., 2004) and control
focal complex dynamics, migration, and NADPH oxidase acti-
vation. Using GST fusions of the PAK1 Cdc42–Rac1 interaction
binding (CRIB) domain or the rhotekin Rho-binding domain
in pull-down assays, we found that Myr-TRAF4 stimulated
GTP loading of Cdc42, Rac1, and RhoA (Fig. 5 A). Further-
more, Rac1(N17) diminished Myr-TRAF4–induced RhoA
activation, whereas RhoA(N19) had no effect on Rac1 or
Cdc42 activation (Fig. 5, B and C). Thus, TRAF4 activates
Cdc42 and Rac1 upstream of RhoA, which is consistent with
the sequence of Rho GTPase activation during spontaneous
focal contact formation after matrix attachment (Nobes and
Hall, 1995). Confirming the activation of Rho GTPases in
vivo, Myr-TRAF4 constitutively activated the Cdc42 and
Rac1 effector PAK1 (Fig. 5 D). In some cells (presumably
high transgene expressors), actin cytoskeletal collapse was
noted (Fig. S4, available at http://www.jcb.org/cgi/content/
full/jcb.200507004/DC1), which is a morphology resulting
from the expression of active PAK1 mutants (Manser et al.,
1997) or agonist-dependent PAK1 activation (Wu et al.,
2004). Indeed, adenoviral delivery of kinase-dead PAK1(K298A)
completely suppressed Myr-TRAF4–induced cytoskeletal re-
modeling (Fig. S4).
Figure 5. Myr-TRAF4 activates Rho family GTPases and PAK1. (A) HUVECs
were transfected with empty vector, native TRAF4 (wt), or Myr-TRAF4. After
24 h, cells were lysed, and GTP-loaded Rho proteins were captured with
GST-CRIB or GST–Rho-binding domain. Immunoblots for Cdc42, Rac1,
and RhoA are shown in lysates and after capture. (B and C) HUVECs were
transfected with the indicated vectors, infected with Ad-lacZ, Ad-RhoA(N19),
or Ad-Rac1(N17) (MOI   100:1), and RhoA, Rac1, and Cdc42 activity
were assessed. Myr-TRAF4 activated Cdc42 and Rac1 upstream of RhoA.
(D) HUVECs were transfected with the indicated plasmids and assessed
for PAK1 activity by immunoprecipitation kinase. Phosphorylation of myelin
basic protein (top) and immunoblot for captured PAK1 (bottom) are
shown. Myr-TRAF4 but not wtTRAF4 activated PAK1.
Figure 6. Myr-TRAF4 activates the NADPH oxidase through PAK1. (A)
Phoenix-293 cells overexpressing wt-p47
phox were transfected with the
indicated plasmids. Whole cell lysates were immunoblotted for p47
phox
(pS328) and reprobed for total p47
phox, demonstrating phosphorylation of
p47(S328) by Myr-TRAF4. (B) HUVECs were cotransfected with DsRed
and one of the indicated plasmids and were infected with Ad-lacZ or Ad-
p67(V204A). DCF fluorescence of adherent DsRed-expressing cells was
quantified by image analysis as described in Oxidant production. Myr-
TRAF4–induced oxidant production was blocked by p67(V204A). (C)
HUVECs were cotransfected with DsRed and the indicated plasmids,
and oxidant production of DsRed-expressing cells was measured without
manipulation. The PAK inhibitory domain (PID(wt)) but not its nonbind-
ing mutant (PID(LF)) decreased Myr-TRAF4–induced oxidant production.
(B and C) *, P   0.05 compared with control; 
†, P   0.05 compared with
Myr-TRAF4 alone. Error bars represent SEM. 
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PAK1 not only targets focal complexes (Manser et al.,
1998; Zhao et al., 2000) and becomes active within membrane
rafts (Krautkramer et al., 2004), but it has been shown to act
upstream of the NADPH oxidase in endothelial cells (Wu et
al., 2003, 2004). An early event in oxidase activation is the
serine phosphorylation of p47
 
phox
 
, which unmasks binding do-
mains (Faust et al., 1995). To assess NADPH oxidase activa-
tion, we developed antisera against p47
 
phox
 
 phosphorylated on
S328, a key phosphorylation site (Ago et al., 1999), and found
that the expression of Myr-TRAF4 in Phoenix-293 cells in-
creased p47
 
phox
 
 S328 phosphorylation (Fig. 6 A). Accordingly,
Myr-TRAF4 increased oxidant production in HUVECs, and
this oxidant production was decreased by the NADPH oxi-
dase–specific transdominant antagonist p67(V204A) (Fig. 6 B).
Furthermore, oxidant production was completely blocked by
the PAK inhibitory domain (PID), which binds and inhibits the
PAK kinase domain (Fig. 6 C). In contrast, the PID harboring
an equivalent of the PAK1(L107F) mutant, which was pre-
dicted to disrupt this interaction (Frost et al., 1998), had no
significant effect. Thus, Myr-TRAF4 activates Rac1 and in-
creases oxidant production through PAK1-dependent NADPH
oxidase activation.
 
Myr-TRAF4 oxidatively modifies 
PTP-PEST
 
A prominent and perhaps central mechanism by which oxidants
exert their effects on signaling pathways is through oxidative
modification of the conserved catalytic cysteine of protein
tyrosine phosphatases, rendering them inactive (Meng et al.,
2002). PTP-PEST represents a potential oxidant target because
it binds Hic-5, targets nascent focal contacts, blocks integrin-
dependent Rac1 activation, and modulates cell migration
(Angers-Loustau et al., 1999; Nishiya et al., 1999; Sastry et al.,
2002). Therefore, we examined oxidative inactivation of PTP-
PEST by assessing its covalent labeling with 5
 
 
 
-iodoacetamido-
fluorescein (5-IAF), which is known to selectively react with
the acidic catalytic cysteine thiol of active PTPs (Wu et al.,
1998). We found that Myr-TRAF4 increased oxidative modi-
fication (decreased 5-IAF labeling) of the acidic cysteine of
coexpressed PTP-PEST in Phoenix-293 cells (Fig. 7 A). The
expression of p67(V204A) completely prevented this oxidative
modification, which is consistent with the predominant effect
of the NADPH oxidase on PTP-PEST.
To assess the specificity of this effect, we examined the
effect of Myr-TRAF4 on two other PTPs. First, MAPK phos-
Figure 7. Myr-TRAF4 oxidatively modifies the
focal contact phosphatase PTP-PEST through
the NADPH oxidase. (A) Phoenix-293 cells
were transfected with either empty vector or
Myr-TRAF4. In top panels, cells were cotrans-
fected with Flag–PTP-PEST. p67(V204A) was
adenovirally transduced. Lysates were labeled
with 5-IAF, and the indicated PTPs were immuno-
precipitated and immunoblotted for fluorescein
to detect 5-IAF labeling and for the respective
PTPs to assess capture. Myr-TRAF4 decreased
5-IAF labeling of PTP-PEST, indicating oxidative
modification of the active site cysteine. 5-IAF
labeling of MKP-1 and SHP-2 was unaffected.
Error bars represent SEM. (B) Immunofluores-
cent images were obtained with TIRF micros-
copy showing colocalization of p47
phox,
TRAF4, and Hic-5 (AlexaFluor488 or 633)
with phosphotyrosinylated proteins (Alexa-
Fluor555) within peripheral dots at the edges
of protrusions. In bottom panels, endogenous
TRAF or Hic-5 were knocked down in HU-
VECs as indicated. Bars, 10  m. (C) HU-
VECs were transfected with the indicated plas-
mids and infected with the indicated Ad
viruses. 200  M MnTMPyP was present for 3 h
before lysis. Rac1 GTP loading was assessed
by binding to GST-CRIB. Both MnTMPyP and
p67(V204A) blocked Myr-TRAF4–induced
Rac1 activation. 
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phatase (MKP-1) is also oxidant sensitive (Kamata et al., 2005)
but largely cytosolic and, thus, is not expected to be targeted by
TRAF4-directed oxidants. Indeed, Myr-TRAF4 had no effect
on 5-IAF labeling of MKP-1 (Fig. 7 A). More interestingly,
SHP-2 is also oxidant sensitive (Meng et al., 2002) and, in ad-
dition, controls integrin signaling (Lacalle et al., 2002). Unlike
PTP-PEST, however, SHP-2 appears to govern insulin signal-
ing and stable focal adhesion dynamics and does so through
control of RhoA, not Rac1 (Manes et al., 1999; Inagaki et al.,
2000; Kontaridis et al., 2004). Accordingly, we found that
Myr-TRAF4 did not affect 5-IAF labeling of SHP-2, suggest-
ing that the effects of TRAF4-linked oxidants are not general-
ized for all integrin structures and that they possess some de-
gree of specificity for PTP-PEST. As a further demonstration
that the TRAF4–oxidase complex facilitates tyrosine phosphor-
ylation of integrin aggregates, we found using immunofluores-
cence that endogenous Hic-5, TRAF4, and p47
 
phox
 
 colocalized
with tyrosine-phosphorylated structures at the edge of mem-
brane protrusions (Fig. 7 B). These findings are consistent with
the accumulation of tyrosine-phosphorylated proteins within
focal complexes (Allen et al., 1997). Knockdown of either
TRAF4 or Hic-5 qualitatively decreased but did not abolish
focal contact tyrosine phosphorylation and decreased p47
 
phox
 
association with focal contacts. As expected, the knockdown of
Hic-5 also decreased the targeting of TRAF4 to tyrosine-phos-
phorylated structures (Fig. 7 B).
Although our data indicate that TRAF4 activates a Rac1/
PAK1/NADPH oxidase cascade, leading to oxidative inactiva-
tion of PTP-PEST, the latter phosphatase in its active form has
been shown to decrease attachment-dependent Rac1 activation,
possibly feeding back upstream in this cascade (Sastry et al.,
2002). Were this the case, Rac1-dependent oxidant production
would be expected to further increase Rac1 activity, thereby
engaging in a positive feedback cycle. To test this hypothesis,
we examined the effect of the NADPH oxidase on its upstream
activator, Rac1. Indeed, both MnTMPyP and p67(V204A)
completely suppressed Myr-TRAF4–induced Rac1 GTP loading
(Fig. 7 D), placing the oxidase both upstream and downstream of
TRAF4-dependent Rac1 activation.
 
TRAF4-dependent membrane ruffling 
proceeds through Rac1, PAK1, and the 
NADPH oxidase
 
The expression of Myr-TRAF4 by endothelial cells caused dra-
matic membrane ruffling on multiple edges with a concentration
of DsRed-p47 within ruffles, suggesting diffuse constitutive
activation of Rac1 and PAK1 and high focal complex turnover
(Fig. 8 A). Extensive lamella formation was occasionally seen
in conjunction with ruffling (not depicted). As expected,
Rac1(N17) diminished ruffling to basal levels (Fig. 8 B). In ad-
dition, kinase-inactive PAK1(K298A) and wild-type PID (but
not the inactive PID[LF] mutant peptide) also blocked Myr-
TRAF4–induced ruffling (Fig. 8 B). Finally, both MnTMPyP
and p67(V204A) reduced Myr-TRAF4–induced ruffling to
basal levels (Fig. 8 C). Thus, by morphological as well bio-
chemical criteria, Rac1, PAK1, and the NADPH oxidase act
downstream of TRAF4.
If PTP-PEST were an essential target in TRAF4-directed
oxidant signaling, a specific decrease in PTP-PEST activity
independent of TRAF4 should similarly be manifested as an
increase in ruffling. Indeed, siRNA-mediated knockdown of
Figure 8. Myr-TRAF4 induces marked membrane ruffling through Rac1,
PAK1, and the NADPH oxidase. (A) HUVECs were cotransfected with ei-
ther empty vector or Myr-TRAF4 and either actin-GFP or DsRed-p47.
Myr-TRAF4–induced ruffling is seen on multiple edges of cotransfected
cells (middle). Ruffles contained DsRed-p47 (right). (B and C) HUVECs
were cotransfected with actin-GFP and either empty vector (first bar)
or Myr-TRAF4 and additionally with one of the indicated plasmids.
PAK1(K298A) and p67(V204A) were expressed via adenoviral transduc-
tion. 100  M MnTMPyP was added for 1 h. Inhibition of PAK1, the
NADPH oxidase, Pyk2, or Src decreased the percentage of cells ruffling in
response to Myr-TRAF4. *, P   0.05 compared with vector control; 
†, P  
0.05 compared with Myr-TRAF4 alone. (D) HUVECs were transfected with
siRNA against PTP-PEST. Immunoblot shows protein levels after 48 h. PTP-
PEST knockdown increased the percentage of ruffling cells. *, P   0.05
compared with control siRNA. Expression of p67(V204A) had no effect
on the ruffling rate in PTP-PEST knockdown cells. Examples are shown below.
Error bars represent SEM. Bars, 20  m. 
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PTP-PEST promoted robust membrane ruffling in the absence
of Myr-TRAF4 (Fig. 8 D). This effect is similar to the enhance-
ment in ruffling elicited by the expression of the catalytically
inactive PTP-PEST(C321S) (Sastry et al., 2002), which, in the-
ory, should behave like an oxidatively inactivated phosphatase.
The expression of p67(V204A) had no effect on this ruffling,
which is consistent with the effects of the NADPH oxidase up-
stream of PTP-PEST inactivation. Although it is not clear that
all of the effects of TRAF4-directed oxidant production funnel
through PTP-PEST inactivation, the depletion of active PTP-
PEST appears to be at least sufficient to mediate ruffling.
PTP-PEST antagonizes the effects of the tyrosine kinase
Pyk2 (Lyons et al., 2001). The latter protein, which is associ-
ated with the p47
 
phox
 
–TRAF4–Hic-5 complex (Fig. 3 C), acts as
a scaffold for another focal complex tyrosine kinase, Src, and
facilitates Src activation (Park et al., 2004). Src, in turn, medi-
ates focal complex turnover much like active PAK1 (Manser et
al., 1997; Zhao et al., 2000; Webb et al., 2004). Accordingly,
we found that kinase-dead mutants of both Pyk2 and Src also
caused Myr-TRAF4–transfected endothelial cells to lose
membrane ruffles and become quiescent (Fig. 8 C), which is
consistent with the focusing of TRAF4’s effects on focal
complex tyrosine phosphorylation events related to PTP-PEST.
Finally, as many of the proteins implicated in TRAF4 sig-
naling (including TRAF4 itself, Rac1, PAK1, the NADPH
oxidase cytochrome subunits, integrins, and Src) congregate
within membrane rafts, it was not surprising to find that the dis-
ruption of raft structure with either filipin (not depicted) or
methyl-
 
 
 
 cyclodextrin (Fig. S5, available at http://www.jcb.
org/cgi/content/full/jcb.200507004/DC1) effectively diminished
Myr-TRAF4–induced ruffling and lamellipodium formation.
Although not specific for the TRAF4 complex, these data sup-
port the concept that TRAF4 operates within an expected mi-
crodomain to participate in Rac1-dependent integrin signaling.
 
Discussion
 
By sequence homology and domain organization, human
TRAF4 is closer to the canonical 
 
Drosophila melanogaster
 
orthologue dTRAF1 than to all other mammalian TRAF
members, suggesting an early evolutionary and functional bi-
furcation of TRAF4 from other human TRAFs. Indeed, no
immunological defects have been identified to date in mice
lacking TRAF4. Instead, TRAF4 deficiency leads to defective
ontogenic migration, resulting in incomplete neural tube and
branchial arch closure (Regnier et al., 2002). Accordingly,
TRAF4 was originally cloned based on its differential expres-
sion in metastatic breast cancer tissues (Tomasetto et al., 1995),
suggesting a link between TRAF4 and the epithelial–mes-
enchymal transition. In endothelial cells, TRAF4 controls
NADPH oxidase–dependent activation of JNK (a MAPK in-
volved in migration) through disparate agonists invoked in
angiogenesis (Xu et al., 2002). Similarly, the fly orthologue
dTRAF1 was originally identified by its involvement in the
Misshapen/JNK cassette that controls cell migration during fly
embryogenic dorsal closure downstream from Rho/Rac (Liu et
al., 1999; Lu and Settleman, 1999). The loss of dTRAF1 also
results in the failure of JNK activation during metamorphosis
with impaired dorsal thoracic closure (Cha et al., 2003). Despite
these inferences, however, TRAF4 has not previously been
placed within a pathway that is relevant to cell migration.
Our data suggest that during cell migration, TRAF4 may
tether p47
 
phox
 
 to nascent lamellar focal complexes to direct oxi-
dant production to these structures and bias the local environ-
ment toward tyrosine phosphorylation events and Rho GTPase
activation. We provide microscopic, biochemical, and func-
tional evidence for such targeting. First, we found that both
chromophore fusions of TRAF4 and p47
 
phox
 
 as well as the en-
dogenous proteins are targeted to leading edge focal com-
plexes, which are integrin-associated structures concentrated
with tyrosine-phosphorylated proteins. This physical targeting
of an NADPH oxidase subunit to such structures is consistent
with the influence of integrin ligation on oxidase activation; for
instance, either the detachment or reattachment of cells to the
matrix induces NADPH oxidase–dependent oxidant production
(Kheradmand et al., 1998; Chiarugi et al., 2003). The appear-
ance of TRAF4 in membrane rafts is also consistent with its
functional interaction with integrin structures and the NADPH
oxidase. Matrix attachment, for instance, directs 
 
 
 
1
 
 and 
 
 
 
3
 
 inte-
grins into raft domains (Lacalle et al., 2002; Labrecque et al.,
2003); in addition, the NADPH oxidase membrane–associated
cytochrome 
 
b
 
558
 
 (gp91
 
phox
 
 and p22
 
phox
 
), like TRAF4, is constitu-
tively associated with lipid rafts (Vilhardt and Van Deurs,
2004). The further appearance of Src, Rac1, and RhoA in rafts
after integrin ligation also suggests the importance of rafts as
organizing structures involved in focal complex dynamics.
Second, we found evidence that a functional complex is
formed along with the focal contact protein Hic-5. TRAF4
binds Hic-5 and forms a complex with the focal adhesion kinase
Pyk2, a redox-sensitive kinase previously shown to mediate
VEGF-induced endothelial cell migration (Avraham et al.,
2003). Accordingly, knockdown of either TRAF4, Hic-5, or
binding truncations of either protein disrupt VEGF-mediated
chemotaxis and sheet migration into wounds. The association
of TRAF4 with Hic-5 suggests a mechanism of specifying oxi-
dase activation to integrin complexes and potentially places
such a complex in proximity to other oxidant-related, Hic-5–
associated proteins. These include PAK1, which associates
with Hic-5 through paxillin-kinase linker (Turner et al., 1999)
and both associates with p47
 
phox
 
 and acts upstream of its phos-
phorylation (Wu et al., 2003, 2004); Pyk2, which binds to the
NH
 
2
 
 terminus of Hic-5 (Matsuya et al., 1998) and requires en-
dogenous oxidants for integrin-dependent mechanosensory
activation (Tai et al., 2002); and Src, which binds Pyk2 (Mat-
suya et al., 1998; Park et al., 2004), phosphorylates Hic-5
(Matsuya et al., 1998; Ishino et al., 2000), and becomes active
upon integrin ligation via oxidant production (Chiarugi et al.,
2003). Besides acting up or downstream of endogenous oxi-
dants, all three of these kinases increase focal complex turn-
over and mediate ruffle formation as well as cell migration
(Manser et al., 1997; Kiosses et al., 1999; Timpson et al., 2001;
Okigaki et al., 2003; Webb et al., 2004).
Third, we found that a myristoylated form of TRAF4 ac-
tivates Rho GTPases and the effector kinase PAK1, increases 
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p47
 
phox
 
 phosphorylation and oxidant production, and causes in-
tense membrane ruffling, which is a morphologic correlate of
Rac1 hyperactivation. Our data further suggest that oxidants fa-
cilitate focal complex signaling through the targeted inactivation
of PTP-PEST. This phosphatase binds Hic-5 and translocates to
nascent focal complexlike structures (Angers-Loustau et al.,
1999; Nishiya et al., 1999; Sastry et al., 2002), where it can
gainsay both Pyk2 and Src function (Angers-Loustau et al.,
1999; Lyons et al., 2001). Notably, active PTP-PEST decreases
Rac1 activity and membrane ruffling and is thought to partici-
pate in focal contact turnover (Angers-Loustau et al., 1999;
Sastry et al., 2002; Cousin and Alfandari, 2004). Consistent
with the combined observations that PTP-PEST may act both
up and downstream of Rac1, we found that the NADPH oxidase
may act similarly, thus participating in a possible positive feed-
back loop. Such loops are thought to be critical in sensing and
amplifying shallow chemoattractant gradients and fully polariz-
ing the motile cell (for review see Ridley et al., 2003). Interest-
ingly, these loops involve PI3K, PAK1, and Rho GTPases such
as Rac1, which are all capable of acting upstream of the NADPH
oxidase and are all rapidly mobilized to the leading edge.
 
Materials and methods
Plasmid and adenoviral derivation
Full-length human TRAF4 (Xu et al., 2002) was PCR amplified and sub-
cloned into pDsRed2-N1 or pEGFP-N3 (CLONTECH Laboratories, Inc.) to
create DsRed-TRAF4 and TRAF4-GFP. TRAF4(1–260) was amplified and
subcloned into pCINF to create TRAF4-N. Annealed oligonucleotides en-
coding the NH2-terminal c-Src myristoylation sequence (MGSSKSKP-
KDPSQRRR) were ligated into pCI-neo, and TRAF4 was then inserted in
frame to form Myr-TRAF4. After the creation of BamHI and EcoRI sites,
TRAF4 was subcloned into pGEX-2TK. Full-length Hic-5 was PCR amplified
from a HUVEC cDNA library (Xu et al., 2002), ligated into pCINF in
frame with an NH2-terminal Flag tag, and subcloned into pEGFP-N3 to
form Hic5-GFP. Serial COOH-terminal truncations of Hic-5 ending with
residues 139, 185, 210, 269, 328, and 387 were generated by PCR
from pCINF-Hic5. Hic-5(329–445) and (388–444) corresponding to the
LIM-3,4 and LIM-4 domains were PCR amplified and inserted into pCINF.
PTP-PEST was PCR amplified from a HUVEC library and subcloned into
pCINF. The PAK1 autoinhibitory domain (residues 83–149 of rat PAK1)
was subcloned into pCINF. The PAK1(L107F) mutant was obtained from
Melanie Cobb (University of Texas Southwestern, Dallas, TX), and the cor-
responding mutant PID was subcloned into pCINF. TRAF4(261–470),
p47-GFP, DsRed-p47, pGBKT7-TRAF4, and pCI-TRAF4 were previously
described (Gu et al., 2002; Xu et al., 2002; Wu et al., 2003). All
constructs were sequenced for verification. Zyxin-GFP, DsRed-zyxin,
Src(K295M), and Pyk2(K457A) were gifts from Derek Toomre (Yale Uni-
versity, New Haven, CT), Anna Huttenlocher (University of Wisconsin,
Madison, WI), Serge Roche (Centre de Recherches de Biochimie Macro-
moléculaire, Montpellier, France), and Shalom Avraham (Harvard Univer-
sity, Boston, MA), respectively. Adenoviruses harboring PAK1(K298A),
p67
phox(V204A), and p47
phox(wt) (W193R) and (S303D,S304D,S328D)
mutants were constructed as described previously (Xu et al., 2002; Wu
et al., 2003, 2004). Adenoviruses containing Myc-Rac1(N17) and
RhoA(N19) were gifts from Kaikobad Irani (Johns Hopkins University, Bal-
timore, MD) and Christopher Chen (University of Pennsylvania, Philadel-
phia, PA), respectively (Ozaki et al., 2000; McBeath et al., 2004).
Microscopy
HUVECs were grown in EGM-2 media (Clonetics), electroporated 6–7 h
after release from thymidine-induced cell cycle arrest, and plated on fi-
bronectin-coated chambered coverslips (Lab-Tek). Because endothelial
edge ruffles do not readily withstand fixation/permeabilization, cells were
examined live with sequential acquisition of red and green channels. Con-
focal microscopy was performed using a LSM 410 laser scanning system
(Axiovert S100TV; Carl Zeiss MicroImaging, Inc.). Images were acquired
with either a 63 /1.2 or a 100 /1.3 objective using LSM software
(Carl Zeiss MicroImaging, Inc.). Ruffling was quantified in actin-GFP–
cotransfected cells by examining all cells in at least four high power fields
per chamber in at least four chambers. TIRF microscopy was performed on
live cells using a fluorescent inverted microscope system (TE2000-U; Nikon).
Images were acquired at 37 C with a 60 /1.45 oil immersion objective
(Nikon) using Metamorph software (Molecular Devices).
Immunofluorescence
HUVEC plated on fibronectin-coated chambered coverslips were washed,
fixed with 2% HCHO, and permeabilized with 0.2% Triton X-100. After
subsequent washing, cells were blocked at 25 C for 30 min with either
10% normal goat serum or 5% BSA. Primary antibodies used were Hic-5
(1:50; Santa Cruz Biotechnology, Inc.), TRAF4 (1:50; Santa Cruz Biotech-
nology, Inc.), p47
phox (1:50; Santa Cruz Biotechnology, Inc.), vinculin
(1:100;  clone Vin-11-5; Sigma-Aldrich), and phosphotyrosine (1:200;
clone PT-66; Sigma-Aldrich); these antibodies were incubated with cells at
25 C for 1 h in either 5% goat serum or 2% BSA. Corresponding second-
ary antibodies conjugated to AlexaFluor488, 555, or 633 were obtained
from Invitrogen. Cells were stained with each secondary antibody sepa-
rately with extensive washing in between. Cells were observed with TIRF
microscopy as described above using 488-, 543-, or 633-nm excitation
lines. Corresponding controls without primary antibodies were confirmed
to be negative, and no bleed-through to other channels was observed with
any of the chromophores.
Yeast two-hybrid screening
A HUVEC library was previously constructed in lambda phage HybriZAP
2.1 XR (Xu et al., 2002), and the library was dropped out in the yeast
shuttle vector pAD-GAL4-2.1 by mass excision. Saccharomyces cerevisiae
AH109 (CLONTECH Laboratories, Inc.) were sequentially transformed
with the bait vector pGBKT7-TRAF4 and with the endothelial library using
lithium acetate. Candidate prey were identified with adenine and histidine
auxotrophic selection and lacZ expression. Single yeast clones were re-
tested for auxotrophy and lacZ expression, and library plasmids were
passaged  through  Escherichia coli and confirmed with standard yeast
mating techniques. Interactions were assessed using yeast mating tech-
niques, with the assessment of lacZ expression by diploids. In vitro pull
down was performed as previously described (Xu et al., 2002).
Coimmunoprecipitation
Phoenix-293 cells electroporated with indicated vectors were extracted in
lysis buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 1% Triton X-100, 2.5 mM Na pyrophosphate, 1 mM  -glycero-
phosphate, 1 mM Na3VO4, 1  g/ml leupeptin, and 1 mM PMSF) for 30
min on ice, sonicated for 5 s, and centrifuged at 10,000 g for 20 min at
4 C. Immunoprecipitation was then performed using protein A or protein
G–agarose (GE Healthcare) conjugates. Antibodies used are as follows:
TRAF4 (Santa Cruz Biotechnology, Inc.), Flag (Sigma-Aldrich), Hic-5 and
Pyk2 (BD Transduction), and p47
phox (Upstate Biotechnology and gift of
Bernard Babior, Scripps Research Institute, La Jolla, CA). In some experi-
ments, human lung microvascular endothelial cells or HUVECs (both from
Clonetics) were used.
Protein knockdown
RNA corresponding to both strands of human Hic-5 (803–821), TRAF4
(175–193), and PTP-PEST (1584–1602; coding region numbering) tailed
with dTdT were synthesized by Dharmacon. A sequence from firefly lu-
ciferase was used as a control siRNA in all experiments. 10 nM duplex
siRNA was transfected into HUVEC using 30  l TransIT-TKO (Mirus) per
100-mm dish. Protein expression was assessed, and experiments were ini-
tiated after 48 h.
Migration assays 
The bottom of 24-well transwell filters (0.8  m; Costar) was coated with
fibronectin (Sigma-Aldrich). HUVECs were cotransfected with pEGFP
(CLONTECH Laboratories, Inc.) and one of the indicated vectors. 24 h
after transfection, cells were plated onto filters in growth factor–deficient
EBM2 media (Clonetics) with 2% FBS. The bottom chamber contained the
same media plus 100 ng/ml VEGF (PeproTech). Cells were allowed to
migrate for 16 h, and then cells remaining on the top surface were re-
moved with a cotton swab and GFP-positive cells were counted. After
counting, cells were swabbed off the bottom surface, and the filters
were reexamined to confirm the removal of remaining cells. Migration
into wounds was examined by plating pEGFP-cotransfected HUVECs on
fibronectin-coated etched coverslips (Bellco). At least five wounded fields
per coverslip were analyzed on six coverslips per condition, and identicalOXIDANTS AND CELL MIGRATION • WU ET AL. 903
fields were photographed under phase and epifluorescence at 0, 18, 24,
and 48 h. Phase-contrast and GFP images were overlaid and analyzed
using Metamorph software.
Raft fractionation
Detergent-insoluble low density fractions were isolated as described previ-
ously (Lee et al., 2002). Five 100-mm dishes per condition were pooled,
washed twice with PBS, and resuspended in 1 ml MES-buffered saline
(MBS; 25 mM MES, pH 6.5, 150 mM NaCl, and 5 mM EDTA) with 1%
Triton X-100 and protease inhibitors. Cells were disrupted with 10 passes
through a 25-gauge needle and diluted with 1 ml 80% sucrose in MBS.
Lysate was overlaid with 2 ml of 30% and 1 ml of 5% sucrose in MBS and
centrifuged at 200,000 g for 18 h at 4 C with a rotor (SW55Ti; Beckman
Coulter). 0.4-ml fractions were removed from the top, acetone precipitated
twice, washed in acetone, and resuspended in Laemmli buffer. Antibodies
for caveolin-1, Rac1, TfR, and TRAF4 were obtained from Santa Cruz Bio-
technology, Inc.
Rho family GTP loading
The human PAK1 CRIB domain (residues 51–135) was recovered by PCR
from a HUVEC library and ligated into pGEX-2TK, and the Rho-binding
domain of mouse rhotekin (residues 7–89) was recovered by RT-PCR from
mouse endothelial cells and ligated into pGEX-2TK. GST fusion proteins
were then produced in BL21-RP bacteria and captured on glutathione
S-transferase–Sepharose beads (GE Healthcare). Active GTP-loaded Rho
proteins from the 10,000-g supernatant of HUVEC lysate were pulled
down by the respective fusions and immunoblotted with antisera for Rac1
(BD Transduction), Cdc42 (Santa Cruz Biotechnology, Inc.), or RhoA
(Santa Cruz Biotechnology, Inc.).
PAK1 activity 
PAK1 activation was assessed by an immunoprecipitation kinase assay
(Wu et al., 2004). In brief, HUVECs were extracted in cold lysis buffer,
sonicated briefly, centrifuged, and immunoprecipitated with rabbit anti-
PAK1 (Santa Cruz Biotechnology, Inc.). The kinase reaction was per-
formed using 5  g myelin basic protein as a substrate in the presence of
 -[
32P]ATP at 30 C for 30 min. Two thirds of each sample was subjected
to autoradiography, and one third was subjected to immunoblotting to
assess the capture of PAK1.
p47
phox phosphorylation 
Rabbit polyclonal antisera was raised by immunization with a keyhole
limpet hemocyanin–conjugated peptide YRRN(pS)VRFLQQRR containing a
phosphoserine corresponding to S328 of human p47
phox. The antisera spe-
cifically recognized p47
phox phosphorylated in vivo by phorbol ester stimu-
lation. Phoenix-293 cells overexpressing p47
phox were transfected with
pCIN, Myr-TRAF4, or TRAF4, and whole cell lysates were serially immuno-
blotted for p47
phox(pS328) and total p47
phox (Upstate Biotechnology).
Oxidant production 
HUVECs were cotransfected with pDsRed-C2 and the test vectors, plated
on fibronectin-coated slides, and subsequently infected with adenovirus
(multiplicity of infection [MOI]   100:1). After 24 h, cells were washed
twice with warm HBSS and incubated with 10  M dichlorodihydrofluores-
cein diacetate (DCF) for 40 min. Cells were washed twice in HBSS, and
epifluorescent green and red channel images were acquired with cells in
an adherent state to avoid perturbation of integrin activity. DCF fluores-
cence of DsRed-expressing cells was quantified in 16-bit resolution using
Metamorph software. The mean of at least 20 cells per chamber in 10
chambers was quantified for each condition.
5-IAF labeling 
Oxidation of protein tyrosine phosphatase acidic cysteine residues was
assessed as described previously (Wu et al., 1998). Phoenix-293 cells
were cotransfected with Flag–PTP-PEST and either empty vector or Myr-
TRAF4. After lysis, extracts were labeled with 5  M 5-IAF (Invitrogen) at
4 C for 60 min, immunoprecipitated with anti-Flag, and immunoblotted
with rabbit antifluorescein (Invitrogen). MKP-1 and SHP-2 (SH-PTP2) were
similarly immunoprecipitated (Santa Cruz Biotechnology, Inc.) and sub-
jected to immunoblot with antifluorescein.
Online supplemental material
Fig. S1 shows that TRAF4-GFP colocalizes with DsRed-zyxin in focal com-
plexlike structures. Fig. S2 shows that TRAF4-GFP colocalizes with DsRed-
zyxin in TIRF microscopy. Fig. S3 shows that TRAF4 concentrates in low
density detergent-insoluble membrane fractions. Fig. S4 shows examples
of Myr-TRAF4–induced PAK1-dependent cytoskeletal collapse. Fig. S5
shows that Raft disruption decreases Myr-TRAF4–induced ruffling. Online
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200507004/DC1.
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